Accuray (ARAY) Change in Accured Expenses (2010 - 2023)
Accuray's (ARAY) quarterly Change in Accured Expenses came in at -$6.9 million in Q4 2023, up 30.97% year-on-year from -$5.3 million in Q4 2022, and down 435.69% quarter-over-quarter from $2.1 million in Q3 2023.
Accuray (ARAY) Change in Accured Expenses (2010 - 2023) Analysis & Trends
Accuray's Change in Accured Expenses history runs 14 years deep, the most recent figure standing at -$6.9 million for Q4 2023.
- On a quarterly basis, Change in Accured Expenses rose 30.97% year-over-year to -$6.9 million in Q4 2023; TTM through Dec 2023 was -$15.4 million, a 130.28% decrease from a year earlier, with the FY2025 full-year figure at -$5.9 million, up 64.22% from the prior year.
- Change in Accured Expenses slipped to -$6.9 million in Q4 2023 per ARAY's latest filing, from $2.1 million in the prior quarter.
- Across five years, Change in Accured Expenses topped out at $9.4 million in Q2 2019 and bottomed at -$14.1 million in Q3 2019.
- The 5-year median for Change in Accured Expenses is $121000.0 (2020), against an average of -$664352.9.
- Across the five-year window, Change in Accured Expenses surged 212.56% in 2020 and sank 585.71% in 2022, its largest moves.
- Year by year, Change in Accured Expenses stood at $3.0 million in 2019, then jumped by 212.56% to $9.4 million in 2020, then tumbled by 48.97% to $4.8 million in 2021, then sank by 308.31% to -$10.0 million in 2022, then jumped by 30.97% to -$6.9 million in 2023.
- Per Business Quant, the three latest ARAY Change in Accured Expenses figures stand at -$6.9 million (Q4 2023), $2.1 million (Q3 2023), and -$623000.0 (Q1 2023).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.39 Bn | 174.10 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.38 Bn | 125.50 Bn | 3.81 Bn | -654.00 Mn |
| 3 | Medtronic | 107.68 Bn | 98.46 Bn | 6.41 Bn | 123.00 Mn |
| 4 | Boston Scientific | 67.98 Bn | 66.53 Bn | 3.61 Bn | -512.00 Mn |
| 5 | Edwards Lifesciences | 47.81 Bn | 44.13 Bn | 1.29 Bn | -347.10 Mn |
| 6 | GE HealthCare Technologies | 28.53 Bn | 26.25 Bn | 1.98 Bn | -250.00 Mn |
| 7 | Dexcom | 28.35 Bn | 27.24 Bn | 750.30 Mn | 145.10 Mn |
| 8 | Smith & Nephew | 26.78 Bn | 26.20 Bn | - | - |
| 9 | Koninklijke Philips | 25.34 Bn | 22.21 Bn | 2.07 Bn | 21.07 Mn |
| 10 | Accuray | 29,658.93 | -38.50 Mn | 25.29 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -6.89 Mn |
| Dec 31, 2023 | -6.89 Mn |
| Sep 30, 2023 | 2.05 Mn |
| Sep 30, 2023 | 2.05 Mn |
| Mar 31, 2023 | -623,000.00 |
| Mar 31, 2023 | -623,000.00 |
| Dec 31, 2022 | -9.97 Mn |
| Dec 31, 2022 | -9.97 Mn |
| Sep 30, 2022 | 1.85 Mn |
| Sep 30, 2022 | 1.85 Mn |
| Mar 31, 2022 | -3.37 Mn |
| Mar 31, 2022 | -3.37 Mn |
| Dec 31, 2021 | 4.79 Mn |
| Dec 31, 2021 | 4.79 Mn |
| Sep 30, 2021 | -2.30 Mn |
| Sep 30, 2021 | -2.30 Mn |
| Mar 31, 2021 | 693,000.00 |
| Mar 31, 2021 | 693,000.00 |
| Dec 31, 2020 | 9.38 Mn |
| Dec 31, 2020 | 9.38 Mn |